A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study
一项随机、双盲、多中心、平行组、前瞻性研究，比较 CT-P13 和创新药物英夫利昔单抗在强直性脊柱炎患者中的药代动力学、安全性和疗效：PLANETAS 研究
期刊:Annals of the Rheumatic Diseases
影响因子:20.3
doi:10.1136/annrheumdis-2012-203091
Won Park, Pawel Hrycaj, Slawomir Jeka, Volodymyr Kovalenko, Grygorii Lysenko, Pedro Miranda, Helena Mikazane, Sergio Gutierrez-Ureña, MieJin Lim, Yeon-Ah Lee, Sang Joon Lee, HoUng Kim, Dae Hyun Yoo, Jürgen Braun
